Journal of Molecular Medicine, 2026 Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome Ulutekin C., Can A., Súkeníková L. et al. Olink Target 96Immunological & Inflammatory DiseasesNeurologyPathophysiologySerumCSF | | | | |
Journal of Proteome Research, 2026 Identification of Age-Associated Circulating Proteins and Lipids in 3800 Comorbidity-Enriched Older Adults from Japan-Based Cohorts Using Olink Assays and MRM Mass Spectrometry Tokuoka S., Hamano F., Kobayashi A. et al. Olink Target 96Olink Target 48AgingTechnical EvaluationPlasmaSerum | | | | |
Medicine, 2026 Causal effects of circulating inflammatory proteins on COPD: A Mendelian randomization study Long H., Chen D., Chu L. et al. Olink Target 96Respiratory DiseasesPathophysiologyPlasma | | | | |
Medicine, 2026 Gut microbiota influences gastric cancer through the mediation of inflammatory proteins: A Mendelian randomization analysis Yu C., Wang F., Zhang X. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Journal of Advanced Research, 2026 Processed meat intake and incident gout: Integrated evidence from epidemiology, plasma proteomics, and machine learning Wang Z., Shi D., Pan X. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesOrthopedicsPathophysiologyPlasma | | | | |
Journal of the American Heart Association, 2026 Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank Sakr S., Medina‐Inojosa J., Liu C. et al. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
Diabetes, Obesity and Metabolism, 2026 First‐Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial Chee Y., Acharyya S., Liew H. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Nature Cardiovascular Research, 2026 Depth of neutrophil mobilization stratifies survival in ST-elevation myocardial infarction Richter M., von Göwels J., Fähndrich M. et al. Olink Target 48CVDPathophysiologyPatient StratificationPlasma | | | | |
Communications Medicine, 2026 Integrative proteogenomic analyses identify plasma proteins that impact the risk of ischemic stroke Belbasis L., von Ende A., Gajendragadkar P. et al. Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma | | | | |
Scientific Reports, 2026 Less severe endothelial injury and vascular pathway activation in SARS-CoV-2 Omicron variant compared to Alpha Tiezzi M., Fortini F., Vandenbempt V. et al. Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma | | | | |
Acta Pharmaceutica Sinica B, 2026 Reprogramming gut microbiota and targeting CXCL1: The multifaceted mechanism of PLP1 in ameliorating alcohol-induced liver disease Yang Z., Lv Q., Xu Q. et al. Olink Target 96 MouseHepatologyPathophysiologyMouse Tissue Lysate | | | | |
The Lancet Rheumatology, 2026 Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study Forbes D., Jorgacevic I., Tarn J. et al. Olink Target 96Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
The American Journal of Clinical Nutrition, 2026 Height variation independent of known genetic variants and health in later life: a cohort study Zhang Y., Li Y., Xue X. et al. Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPathophysiologyPlasma | | | | |
JACC: Basic to Translational Science, 2026 Plasma Proteomic Signatures of Left Atrial Dysfunction and Cerebral Small Vessel Disease Tan E., Sim M., Choi H. et al. Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma | | | | |
Metabolism, 2026 Pathophysiology-based subtypes of individuals at high risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes Deng K., Hameete A., Schrauwen P. et al. Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma | | | | |
Clinical Gastroenterology and Hepatology, 2026 Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank Kim H., Rezaee-Zavareh M., Wang Y. et al. Olink Explore 3072/384HepatologyNutritional SciencePathophysiologyPlasma | | | | |
npj Science of Food, 2026 BHOD: a bone health optimized dietary pattern designed for osteoporosis prevention Zheng Y., Li Y., Gao Y. et al. Olink Explore 3072/384Nutritional ScienceOrthopedicsPathophysiologyPlasma | | | | |
BMC Neurology, 2026 A preliminary analysis of the inflammatory protein landscape in the CSF of mid- to late-stage Parkinson’s disease: associations with motor severity and subtypes Guo Y., Liu W., Bu W. et al. Olink Target 96NeurologyPatient StratificationCSF | | | | |
Comprehensive Physiology, 2026 Insight Into the Biological Link Between Novel Adiposity Indices and Incident Heart Failure Yang Y., Li J., Xiao X. et al. Olink Explore 3072/384Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
Frontiers in Medicine, 2026 Reanalysis of the immunological characteristics of scalp psoriasis: a cross-sectional study using Olink proteomics Zhu L., Chen W., Shen N. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyTissue Lysate | | | | |